Beijing Friendship Hospital
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1952-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- https://www.bfh.com.cn
Clinical Trials
186
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (95 trials with phase data)• Click on a phase to view related trials
PBC Long-term Outcomes Study
- Conditions
- Primary Biliary Cholangitis (PBC)Long-term OutcomesPrognosisMulticenter Prospective Study
- First Posted Date
- 2025-09-02
- Last Posted Date
- 2025-09-02
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 4000
- Registration Number
- NCT07149675
- Locations
- 🇨🇳
Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, Select A State Or Province, China
Mazdutide as Adjuvant Therapy Following Sleeve Gastrectomy in Severe Obesity
- Conditions
- Severe Obesity
- Interventions
- Drug: Sleeve gastrectomy plus early mazdutide initiationDrug: Sleeve gastrectomy followed with early mazdutide placebo initation
- First Posted Date
- 2025-08-21
- Last Posted Date
- 2025-08-21
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 256
- Registration Number
- NCT07135141
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, China
🇨🇳Beijing Hospital, Beijing, China
🇨🇳Peking University People's Unviersity, Beijing, China
A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests
- Conditions
- Decompensated CirrhosisHepatitis B Virus (HBV) InfectionMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Alcohol-Related Liver DiseasePortal HypertensionRecompensation
- First Posted Date
- 2025-07-25
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 735
- Registration Number
- NCT07087041
- Locations
- 🇨🇳
Beijing Ditan Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳Beijing You'an Hospital, Capital Medical University, Beijing, Beijing, China
Prognostic Model for MASLD Related Cirrhosis
- Conditions
- Metabolic Dysfunction Associated Steatotic Liver DiseaseCompensated Cirrhosis
- First Posted Date
- 2025-07-24
- Last Posted Date
- 2025-07-24
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 228
- Registration Number
- NCT07082751
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳Beijing University of Chinese Medicine Dongfang Hospital, Beijing, Beijing, China
🇨🇳Beijing Hospital of Traditional Chinese Medicine, Beijing, C, China
Non-Invasive Model for Fibrosis Regression in HBV Patients
- Conditions
- Chronic Hepatitis B Virus (HBV) InfectionLiver Fibrosis
- Interventions
- Drug: Nucleos(t)ide Analogs (NA)
- First Posted Date
- 2025-03-13
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Beijing Friendship Hospital
- Target Recruit Count
- 1100
- Registration Number
- NCT06874127
- Locations
- 🇨🇳
Beijing Friendship Hospital, Beijing, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 37
- Next